Scarica l'app Stockscreener
13.94
7.07%
0.92
Dopo l'orario di chiusura:
13.84
-0.10
-0.72%
Zymeworks Inc. Borsa (ZYME) Ultime notizie
Zymeworks signals expanded royalty streams and milestone-driven cash infusions through new approvals and pipeline progression - MSN
Zymeworks Inc. (NASDAQ:ZYME) Q2 2025 Earnings Call Transcript - Insider Monkey
Zymeworks Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year - 富途牛牛
Zymeworks Strengthens Board of Directors with Appointments of Greg Ciongoli and Robert E. Landry - Ariva
Zymeworks Strengthens Leadership with New Board Appointments - TipRanks
Zymeworks Expands Board with Financial Veterans Greg Ciongoli and Robert E. Landry - The Indian Awaaz
Zymeworks Strengthens Board of Directors with Appointments of Greg Ciongoli and Robert E. Landry | ZYME Stock News - GuruFocus
Zymeworks Inc. Appoints Greg Ciongoli and Robert E. Landry to Board of Directors - Quiver Quantitative
Zymeworks appoints two new directors to strengthen board By Investing.com - Investing.com Nigeria
Zymeworks appoints two new directors to strengthen board - Investing.com
Zymeworks Strengthens Board with Healthcare Veterans as Key Trial Results Near - Stock Titan
Will breakout in Zymeworks Inc. lead to full recoveryFree Breakout Entry Signal Confirmation Tool - Newser
Has Zymeworks Inc. formed a bullish divergenceLow Risk Stock Selection Strategy Guide - Newser
Zymeworks Inc. stock trendline breakdownFree Scalable Portfolio Growth Suggestions - Newser
Zymeworks (NASDAQ:ZYME) Announces Earnings Results - MarketBeat
Zymeworks Inc. stock outlook for YEARWealth Accumulation Outlook for Safe Investors - Newser
Zymeworks Inc. Just Reported A Surprise Profit And Analysts Updated Their Estimates - simplywall.st
Earnings Beat: Zymeworks Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models - Yahoo Finance
Is Zymeworks Inc. forming a breakout patternDouble Capital Strategy Picks - thegnnews.com
Can Zymeworks Inc. hit a new high this monthFree Proven Entry Plan With Low Risk Trade - Newser
Zymeworks Inc. (NYSE:ZYME) Receives Average Rating of “Moderate Buy” from Analysts - Defense World
Applying sector rotation models to Zymeworks Inc.Technical Reversal Setup with Risk Limits - Newser
What does recent volatility data suggest for Zymeworks Inc.Stock Price Prediction Using AI Tools - Newser
Why Zymeworks Inc. stock attracts strong analyst attentionFree High Yield Stocks With Buy Confirmation - Newser
Is Zymeworks Inc. affected by consumer sentimentStock Picks with 300% Gain - sisaissue.com
Zymeworks Q2 2025 Earnings Call: Capitalizing on Platform-Driven Innovation and Strategic Execution - AInvest
Zurcher Kantonalbank Zurich Cantonalbank Purchases 4,920 Shares of Zymeworks Inc. (NYSE:ZYME) - Defense World
Zymeworks (NASDAQ:ZYME) Lowered to “Hold” Rating by Wall Street Zen - Defense World
Zymeworks Reports Strong Q2 2025 Financial Performance - The Globe and Mail
Zymeworks Reports Q2 Results and FDA Clearance - The Globe and Mail
Transcript : Zymeworks Inc., Q2 2025 Earnings Call, Aug 07, 2025 - MarketScreener
Zymeworks Inc. 2025 Q2 Earnings and Strategic Progress: A Catalyst for Oncology Innovation and Shareholder Value - AInvest
Zymeworks: Unleashing Long-Term Value Through Royalty-Driven Growth and Strategic Pipeline Execution - AInvest
Zymeworks Inc. 2025 Q2ResultsEarnings Call Presentation (NASDAQ:ZYME) - Seeking Alpha
Earnings call transcript: Zymeworks sees revenue surge in Q2 2025 By Investing.com - Investing.com Nigeria
Earnings call transcript: Zymeworks sees revenue surge in Q2 2025 - Investing.com
Zymeworks Q2 2025 presentation: Revenue quadruples, pipeline advances with new IND - Investing.com Nigeria
Zymeworks Inc (ZYME) Q2 2025 Earnings Call Highlights: Revenue Surge and Strategic Milestones By GuruFocus - Investing.com Canada
Zymeworks Inc (ZYME) Q2 2025 Earnings Call Highlights: Revenue S - GuruFocus
Zymeworks Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Zymeworks Provides Corporate Update and Reports Second Quarter 2025 Financial Results - GlobeNewswire
Zymeworks Turns The Corner With Strong Q2 Results And Partnerships - Finimize
Zymeworks Reports Q2 Earnings, FDA Clearance, and Revenue Growth - AInvest
Zymeworks Inc. (ZYME) Tops Q2 Earnings and Revenue Estimates - Yahoo Finance
Biotech firm Zymeworks' Q2 revenue jumps to $48.7 mln - MarketScreener
When is the best time to exit Zymeworks Inc.Free Multi-Bagger Potential Stock Forecast Tools - Newser
Cwm LLC Increases Stock Holdings in Zymeworks Inc. (NYSE:ZYME) - Defense World
Zymeworks (ZYME) Expected to Announce Quarterly Earnings on Thursday - Defense World
Zymeworks Inc expected to post a loss of 49 cents a shareEarnings Preview - TradingView
Envestnet Asset Management Inc. Sells 4,578 Shares of Zymeworks Inc. (NYSE:ZYME) - Defense World
What is the dividend policy of Zymeworks Inc. stockTriple-digit return opportunities - Jammu Links News
What drives Zymeworks Inc. stock priceStay ahead with daily expert stock picks - Jammu Links News
Is Zymeworks Inc. a good long term investmentBuild wealth faster with consistent investment plans - Jammu Links News
What are analysts’ price targets for Zymeworks Inc. in the next 12 monthsCapitalize on market momentum for profits - Jammu Links News
What is Zymeworks Inc. company’s growth strategyDiscover undervalued opportunities early - Jammu Links News
What are the latest earnings results for Zymeworks Inc.Discover market opportunities others miss - Jammu Links News
1.67%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):